Tight junctions, the epithelial barrier, and Toll-like receptor-4 during lung injury NM Godbole, AA Chowdhury, N Chataut, S Awasthi Inflammation 45 (6), 2142-2162, 2022 | 11 | 2022 |
Mechanism of anti-inflammatory activity of TLR4-interacting SPA4 peptide S Awasthi, G Kumar, V Ramani, V Awasthi, KK Rodgers, J Xie, J Beierle, ... Immunohorizons 5 (8), 659-674, 2021 | 8 | 2021 |
A comprehensive in vitro biological investigation of metal complexes of tolfenamic acid MMU Mazumder, A Sukul, SK Saha, AA Chowdhury, Y Mamun Alexandria Journal of Medicine 54 (1), 23-26, 2018 | 5 | 2018 |
Effects of SPA4 peptide on lipopolysaccharide‐disrupted lung epithelial barrier, injury, and function in a human cell system and mouse model of lung injury AA Chowdhury, NM Godbole, N Chataut, S Kosanke, K Rodgers, ... Physiological reports 10 (13), e15353, 2022 | 3 | 2022 |
Comparative study of anti-hyperlipidemic effect of Zingiber officinale, Momordica charantia, Trigonella foenum-graecum, Dillenia indica and Tamarindus indica. AA Chowdhury, AS Abhijit Sukul, IH Khan, YM Yasir Mamun, ... | 2 | 2015 |
SPA4 Peptide Treatment Reduces the Lipopolysaccharide (LPS)-stimulated CXCL1/KC and Lactate in Primary Mouse Lung Alveolar Epithelial Cells AA Chowdhury, NM Godbole, S Awasthi A46. ECMO, ARDS, AND ACUTE RESPIRATORY FAILURE, A1724-A1724, 2023 | | 2023 |
Stability and structure–activity relationship of the SPA4 peptide under ambient and stressed conditions of lung injury AA Chowdhury, K Rodgers, NM Godbole, S Awasthi RSC advances 13 (27), 18864-18877, 2023 | | 2023 |
Stability and Activity of SPA4 Peptide in Lung Injury Models AA Chowdhury The University of Oklahoma Health Sciences Center, 2023 | | 2023 |
Biological Activity of SPA4 Peptide Against Lipopolysaccharide (LPS)-Induced Injury AA Chowdhury, G Kyere-Davies, SD Kosanke, S Awasthi TP94. TP094 DISCOVERIES IN BACTERIAL AND VIRAL PNEUMONIA PATHOGENESIS, A3885 …, 2021 | | 2021 |